VC-Backed Freenome Plans Cancer Test to Rival Exact Sciences

(Bloomberg) -- Freenome Inc., a startup working on detecting cancer through blood tests, closed on $160 million in new financing and plans to put that money to work in a new study of at least 10,00...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.